Alendronate prevents bone loss and improves tendon-to-bone repair strength in a canine model

Journal of Orthopaedic Research

Volumn 25, Issue 4, 2007, Pages 473-479

  Thomopoulos, Stavros ^a   Matsuzaki, Hironori ^a   Zaegel, Melissa ^a   Gelberman, Richard H ^a   Silva, Matthew J ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

Bisphosphonates; Enthesis; Flexor tendon; Insertion site; Tendon to bone healing

Indexed keywords

ALENDRONIC ACID; MATRIX METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE ATROPHY; BONE DENSITY; BONE REMODELING; CONTROLLED STUDY; DOG; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; FLEXOR TENDON INJURY; MOVEMENT THERAPY; NONHUMAN; OSTEOLYSIS; PREVENTIVE MEDICINE; PRIORITY JOURNAL; SHORT COURSE THERAPY; TENDON RECONSTRUCTION; TENSILE STRENGTH; TISSUE DEGENERATION; TISSUE REPAIR;

ALENDRONATE; ANIMALS; BIOMECHANICS; BONE AND BONES; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; METALLOPROTEASES; MODELS, ANIMAL; TENDON INJURIES; TENDONS; WOUND HEALING;

EID: 34047201901     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20293     Document Type: Article

References (39)

1. Feuerstein M, Miller VL, Burrell LM, et al. 1998. Occupational upper extremity disorders in the federal workforce. Prevalence, health care expenditures, and patterns of work disability. J Occup Environ Med 40:546-555.
2. Kreiger N, Kelsey JL, Harris C, et al. 1981. Injuries to the upper extremity: patterns of occurrence. Clin Plast Surg 8:13-19.
3. Kelsey JL. 1997. Upper extremity disorders: frequency, impact and cost. New York: Churchill Livingstone.
4. Silva MJ, Boyer MI, Ditsios K, et al. 2002. The insertion site of the canine flexor digitorum profundus tendon heals slowly following injury and suture repair. J Orthop Res 20:447-453.
5. Thomopoulos S, Williams GR, Soslowsky LJ. 2003. Tendon to bone healing: differences in biomechanical, structural, and compositional properties due to a range of activity levels. J Biomechan Eng 125:106-113.
6. Silva MJ, Thomopoulos S, Kusano N, et al. 2006. Early healing of flexor tendon insertion site injuries: tunnel repair is mechanically and histologically inferior to surface repair in a canine model. J Ortho Res (in press).
7. Silva MJ, Ritty TM, Ditsios K, et al. 2004. Tendon injury response: assessment of biomechanical properties, tissue morphology and viability following flexor digitorum profundus tendon transection. J Orthop Res 22:990-997.
8. Ditsios K, Boyer MI, Kusano N, et al. 2003. Bone loss following tendon laceration, repair and passive mobilization. J Orthop Res 21:990-996.
9. Galatz LM, Rothermich SY, Zaegel M, et al. 2006. Delayed repair of tendon to bone injuries leads to decreased biomechanical properties and bone loss. J Orthop Res (in press).
10. Kannus P, Leppala J, Lehto M, et al. 1995. A rotator cuff rupture produces permanent osteoporosis in the affected extremity, but not in those with whom shoulder function has returned to normal. J Bone Miner Res 10:1263-1271.
11. Leppala J, Kannus P, Natri A, et al. 1999. Effect of anterior cruciate ligament injury of the knee on bone mineral density of the spine and affected lower extremity: a prospective one-year follow-up study. Calcif Tissue Int 64:357-363.
12. Alfredson H, Nordstrom P, Lorentzon R. 1998. Prolonged progressive calcaneal bone loss despite early weightbearing rehabilitation in patients surgically treated for Achilles tendinosis. Calcif Tissue Int 62:166-171.
13. Wohl GR, Shymkiw RC, Matyas JR, et al. 2001. Periarticular cancellous bone changes following anterior cruciate ligament injury. J Appl Physiol 91:336-342.
14. Rodeo SA, Suzuki K, Deng XH, et al. 1999. Use of recombinant human bone morphogenetic protein-2 to enhance tendon healing in a bone tunnel. Am J Sports Med 27:476-488.
15. Wang CJ, Wang FS, Yang KD, et al. 2005. The effect of shock wave treatment at the tendon-bone interface - an histomorphological and biomechanical study in rabbits. J Orthop Res 23:274-280.
16. Monier-Faugere MC, Friedler RM, Bauss F, et al. 1993. A new bisphosphonate, BM 21.0955, prevents bone loss associated with cessation of ovarian function in experimental dogs. J Bone Miner Res 8:1345-1355.
17. Day JS, Ding M, Bednarz P, et al. 2004. Bisphosphonate treatment affects trabecular bone apparent modulus through micro-architecture rather than matrix properties. J Orthop Res 22:465-471.
18. Ding M, Day JS, Burr DB, et al. 2003. Canine cancellous bone microarchitecture after one year of high-dose bisphosphonates. Calcif Tissue Int 72:737-744.
19. Hu JH, Ding M, Soballe K, et al. 2002. Effects of short-term alendronate treatment on the three-dimensional microstructural, physical, and mechanical properties of dog trabecular bone. Bone 31:591-597.
20. Astrand J, Aspenberg P. 2004. Topical, single dose bisphosphonate treatment reduced bone resorption in a rat model for prosthetic loosening. J Orthop Res 22:244-249.
21. Lin JH, Russell G, Gertz B. 1999. Pharmacokinetics of alendronate: an overview. Int J Clin Pract Suppl 101:18-26.
22. Mashiba T, Turner CH, Hirano T, et al. 2001. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28:524-531.
23. Muhlbauer RC, Bauss F, Schenk R, et al. 1991. BM 21.0955, a potent new bisphosphonate to inhibit bone resorption. J Bone Miner Res 6:1003-1011.
24. Igarashi K, Adachi H, Mitani H, et al. 1996. Inhibitory effect of the topical administration of a bisphosphonate (risedronate) on root resorption incident to orthodontic tooth movement in rats. J Dent Res 75:1644-1649.
25. Yaffe A, Iztkovich M, Earon Y, et al. 1997. Local delivery of an amino bisphosphonate prevents the resorptive phase of alveolar bone following mucoperiosteal flap surgery in rats. J Periodontol 68:884-889.
26. Doschak MR, LaMothe JM, Cooper DM, et al. 2005. Bisphosphonates reduce bone mineral loss at ligament entheses after joint injury. Osteoarthritis Cartilage 13: 790-797.
27. Sauty A, Pecherstorfer M, Zimmer-Roth I, et al. 1996. Interleukin-6 and tumor necrosis factor alpha levels after bisphosphonates treatment in vitro and in patients with malignancy. Bone 18:133-139.
28. Thiebaud D, Sauty A, Burckhardt P, et al. 1997. An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int 61: 386-392.
29. Yamaguchi K, Motegi K, Iwakura Y, et al. 2000. Involvement of interleukin-1 in the inflammatory actions of aminobisphosphonates in mice. Br J Pharmacol 130: 1646-1654.
30. Endo Y, Nakamura M, Kikuchi T, et al. 1993. Aminoalkylbisphosphonates, potent inhibitors of bone resorption, induce a prolonged stimulation of histamine synthesis and increase macrophage, granulocytes, and osteoclasts in vivo. Calcif Tissue Int 52:248-254.
31. Nakamura M, Ando T, Abe M, et al. 1996. Contrast between effects of aminobisphosphonates and non-amino-bisphosphonates on collagen-induced arthritis in mice. Br J Pharmacol 119:205-212.
32. Shimshi M, Abe E, Fisher EA, et al. 2005. Bisphosphonates induce inflammation and rupture of atherosclerotic plaques in apolipoprotein-E null mice. Biochem Biophys Res Commun 328:790-793.
33. Demirag B, Sarisozen B, Ozer O, et al. 2005. Enhancement of tendon-bone healing of anterior cruciate ligament grafts by blockage of matrix metalloproteinases. J Bone Joint Surg Am 87:2401-2410.
34. Shibata T, Komatsu K, Shimada A, et al. 2004. Effects of alendronate on restoration of biomechanical properties of periodontium in replanted rat molars. J Periodontal Res 39:405-414.
35. Doschak MR, Wohl GR, Hanley DA, et al. 2004. Anti-resorptive therapy conserves some periarticular bone and ligament mechanical properties after anterior cruciate ligament disruption in the rabbit knee. J Orthop Res 22: 942-948.
36. Teronen O, Heikkila P, Konttinen YT, et al. 1999. MMP inhibition and downregulation by bisphosphonates. Ann N Y Acad Sci 878:453-465.
37. Teronen O, Konttinen YT, Lindqvist C, et al. 1997. Human neutrophil collagenase MMP-8 in peri-implant sulcus fluid and its inhibition by clodronate. J Dent Res 76:1529-1537.
38. Nakaya H, Osawa G, Iwasaki N, et al. 2000. Effects of bisphosphonate on matrix metalloproteinase enzymes in human periodontal ligament cells. J Periodontol 71:1158-1166.
39. Rodeo SA, Arnoczky SP, Torzilli PA, et al. 1993. Tendon-healing in a bone tunnel. A biomechanical and histological study in the dog. J Bone Joint Surg Am 75:1795-1803.